関連する実験動画

Updated: Sep 9, 2025

Studying Triple Negative Breast Cancer Using Orthotopic Breast Cancer Model

Studying Triple Negative Breast Cancer Using Orthotopic Breast Cancer Model

Published on: March 20, 2020

新しいSWI/SNF複合体は,トリプルネガティブな乳がんの進行を促進します

Wen-Yi Sheng¹, Yue Zhu¹, Shi-Qi Liu¹

¹Department of Thyroid and Breast Surgery, Nanjing Medical University Affiliated Suzhou Hospital: Suzhou Municipal Hospital, Gusu School, Nanjing Medical University, Suzhou, 215002, China.

Cellular & molecular biology letters

|September 1, 2025

まとめ

ARID1Bは,ZNF382を抑制し,トリプルネガティブ乳がん (TNBC) の成長と移行を促進する新しいSWI/ SNF複合体の成分として作用します. この発見はTNBCの発症の新たなメカニズムと潜在的な治療標的を明らかにした.

科学分野:

腫瘍学
エピジェネティクス
分子生物学

背景:

トリプルネガティブ乳がん (TNBC) は,治療の選択肢が限られている致命的な悪性腫瘍です.
SWI/SNF複合体はクロマチンのアクセシビリティとトランスクリプションを調節する.
付属サブユニットであるARID1Bはクロマチンの調節に作用するが,TNBCにおけるその機能は不明である.

研究の目的:

三重陰性乳がんの病原性におけるARID1Bの役割を明らかにする.
TNBCにおけるARID1B相互作用タンパク質と下流の標的遺伝子を特定する.
ARID1BがTNBCの進行に影響を与えるメカニズムを調査する.

主な方法:

ARID1Bの発現は,免疫光とqRT- PCRを用いて分析された.
ARID1Bの生物学的機能を in vitro 測定と異種移植モデルで評価した.
マススペクトロメトリー,RNA-seq,二重ルシフェラーゼアッセイ,ChIP-qPCRにより,ARID1Bの相互作用と調節メカニズムが特定されました.

主要な成果:

ARID1Bは,その既知のE3ユビキチンリガゼ機能とは対照的に,TNBCにおける予後因子である.
ARID1Bは,SMARCC2とSMARCB1との新しいSWI/SNF複合体を形成することによって,ZNF382を転写的に抑制する.
この複合体はTNBCの増殖と移動を促進し,癌の発生における新たな役割を示しています.

結論:

SWI/SNF複合体内のARID1Bの新機能は,TNBCの進行に極めて重要です.
SWI/SNF複合体の構成と機能を理解することで,TNBCの病原性についての洞察が得られます.
これらの発見は,トリプルネガティブ乳がんの新たな治療戦略につながる可能性があります.

キーワード:

ARID1B についてエピジェネティック・レグレーション SWI/SNF複合体について TNBC について

さらに関連する動画

Three-Dimensional 3D Tumor Spheroid Invasion Assay

Three-Dimensional 3D Tumor Spheroid Invasion Assay

Published on: May 1, 2015

Spheroid Assay to Measure TGF-β-induced Invasion

Spheroid Assay to Measure TGF-β-induced Invasion

Published on: November 16, 2011

関連する概念動画

mTOR Signaling and Cancer Progression

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...

Tumor Progression

Tumor Progression

Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...

Cancer-Critical Genes II: Tumor Suppressor Genes

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...

The Nucleolus

The Nucleolus

The nucleolus is the most prominent substructure of the nucleus. When it was first discovered, it was considered to be an isolated organelle that forms fibrils and granules. In 1931, the relationship between the nucleolus and chromosomes was first described by Heitz. He observed that the appearance and size of nucleolus varies depending on the stage of the cell cycle. He also noticed constricted regions on different chromosomes clustered together at definite cell cycle stages. These regions,...

TGF - β Signaling Pathway

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors...

Adaptive Mechanisms in Cancer Cells

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...